Updated
Reviewed
Jun. 03, 2021

Appendix B: Drug Characteristics Tables

Appendix B, Table 3. Characteristics of Nucleoside Reverse Transcriptase Inhibitors

The older nucleoside reverse transcriptase inhibitors (NRTIs) didanosine (ddI), stavudine (d4T), and zidovudine (ZDV) are no longer used commonly in clinical practice and have been removed from this table. Please refer to the Food and Drug Administration product labels for ddI, d4T, and ZDV for information regarding these drugs.

Appendix B, Table 3. Characteristics of Nucleoside Reverse Transcriptase Inhibitors
   
   
   
   

Appendix B: Drug Characteristics Tables

Appendix B, Table 3. Characteristics of Nucleoside Reverse Transcriptase Inhibitors

The older nucleoside reverse transcriptase inhibitors (NRTIs) didanosine (ddI), stavudine (d4T), and zidovudine (ZDV) are no longer used commonly in clinical practice and have been removed from this table. Please refer to the Food and Drug Administration product labels for ddI, d4T, and ZDV for information regarding these drugs.

Appendix B, Table 3. Characteristics of Nucleoside Reverse Transcriptase Inhibitors
   
   
   
   

Download Guidelines